KIF2C and glioblastoma: However, KIF2C is mainly negatively correlated with ICP genes in COAD, DLBC, GBM, LUAD, LUSC, READ, SKCM, STAD, THYM, and UCEC, which means that targeting KIF2C in such tumors may not achieve favorable immunotherapy outcomes.